Download pdf


Each prolonged-release coated tablet contains 10 mg fampridine.

Mechanism of Action

A potassium channel blocker at the neuronal level. Zilobe is indicated to improve gait in adult patients with multiple sclerosis and a walking disability (EDSS 4-7).

Dosage and Administration

The recommended dose is one 10 mg tablet, twice a day, every 12 hours.

Package Size

A package containing 56 prolonged-release coated tablets.

Exclusive content for Professionals

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
New User Registration
*Required field